Thiotepa/cyclophosphamide/TBI as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients aged 50 years and over.

Source:http://linkedlifedata.com/resource/pubmed/id/18310967

Download in:

View as

General Info

PMID
18310967